These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8537139)

  • 1. Oral cephalosporins for use in a parenteral-to-oral switch programme.
    Rimmer DM
    Infection; 1995; 23 Suppl 2():S87-90. PubMed ID: 8537139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the use of cefixime for switch therapy.
    Low DE
    Infection; 1995; 23 Suppl 2():S91-4. PubMed ID: 8537140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third generation cephalosporins in the parenteral to oral switch.
    Rimmer D
    Pharmacoeconomics; 1994; 5(Suppl 2):27-33. PubMed ID: 10147286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential therapy with intravenous and oral cephalosporins.
    Janknegt R; van der Meer JW
    J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefixime, the first oral third-generation cephalosporin].
    Roche G
    Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
    Sidorenko SV
    Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
    [No Abstract]   [Full Text] [Related]  

  • 7. The penicillins and cephalosporins. Choosing among the newer agents.
    Wagner KF; Counts GW
    Postgrad Med; 1978 Sep; 64(3):109-16. PubMed ID: 100772
    [No Abstract]   [Full Text] [Related]  

  • 8. Cefixime for switch therapy.
    Hamilton-Miller J
    Chemotherapy; 1998 Sep; 44 Suppl 1():24-7. PubMed ID: 9797420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
    Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
    Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New orally active cephalosporin esters.
    Yamada H; Ueda S; Mutoh M; Nagata H; Nouda H; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 May; 43(5):578-83. PubMed ID: 2358409
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and oral activity of ME1207, a new orally active cephalosporin.
    Sakagami K; Atsumi K; Tamura A; Yoshida T; Nishihata K; Fukatsu S
    J Antibiot (Tokyo); 1990 Aug; 43(8):1047-50. PubMed ID: 2211357
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
    Klein JO
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035
    [No Abstract]   [Full Text] [Related]  

  • 13. Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.
    Nathwani D
    Drugs; 2000; 59 Suppl 3():37-46; discussion 47-9. PubMed ID: 10845412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of cephalosporins for hospital formularies.
    Wilson WR
    Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroral preparations of cephalosporin antibiotics].
    Babálová M; Blahová J; Hupková M; Krcméry V
    Cas Lek Cesk; 1994 Jan; 133(1):22-4. PubMed ID: 8111831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research and development of new oral cephems, cefixime and cefdinir].
    Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
    Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology of oral cephalosporins.
    Cullmann W
    Antibiot Chemother (1971); 1995; 47():72-109. PubMed ID: 8554308
    [No Abstract]   [Full Text] [Related]  

  • 19. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative evaluation of oral and parenteral cephalosporins in inhibiting the growth of bacteria pathogenic to the periodontium].
    Fanali S; Paolantonio M; Di Benedetto A; Bascelli A; Tetè S; Piccolomini R
    Minerva Stomatol; 1990 Aug; 39(8):637-40. PubMed ID: 2287333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.